These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29493415)
1. A Medicaid Quality Improvement Collaborative on Psychotropic Medication Prescribing for Children. Thackeray J; Crane D; Fontanella C; Sorter M; Baum R; Applegate M Psychiatr Serv; 2018 May; 69(5):501-504. PubMed ID: 29493415 [TBL] [Abstract][Full Text] [Related]
2. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid. Melvin KE; Hart JC; Sorvig RD Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023 [TBL] [Abstract][Full Text] [Related]
3. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105 [TBL] [Abstract][Full Text] [Related]
4. Improving psychotherapeutic medication prescribing in Florida: implementation of the Florida Medicaid Drug Therapy Management Program (MDTMP). Constantine RJ; McPherson MA; Jones ME; Tandon R; Becker ER Community Ment Health J; 2013 Feb; 49(1):33-44. PubMed ID: 22383046 [TBL] [Abstract][Full Text] [Related]
5. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees. Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275 [No Abstract] [Full Text] [Related]
6. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state. Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148 [TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication use among Kansas Medicaid youths with disabilities. Shireman TI; Reichard A; Rigler SK J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):107-15. PubMed ID: 15741792 [TBL] [Abstract][Full Text] [Related]
8. Prescription of psychotropic medications to youths in office-based practice. Goodwin R; Gould MS; Blanco C; Olfson M Psychiatr Serv; 2001 Aug; 52(8):1081-7. PubMed ID: 11474055 [TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use in children and adolescents in an inpatient setting. Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844 [TBL] [Abstract][Full Text] [Related]
11. An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients. Chiara AN; Kashalikar N; Pomfret TC; Lenz K; Faber DM; Goldstein J; Clements KM; Angelini MC; Leto P; Jeffrey PL J Manag Care Spec Pharm; 2018 Aug; 24(8):746-751. PubMed ID: 30058981 [TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites. Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917 [TBL] [Abstract][Full Text] [Related]
13. [Off-label use of psychotropic medications in pediatric wards: a prospective study]. Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689 [TBL] [Abstract][Full Text] [Related]
14. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Houghton R; Ong RC; Bolognani F Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809 [TBL] [Abstract][Full Text] [Related]
15. Best Practices: MEDNET: a multistate policy maker-researcher collaboration to improve prescribing practices. Finnerty M; Neese-Todd S; Bilder S; Olfson M; Crystal S Psychiatr Serv; 2014 Nov; 65(11):1297-9. PubMed ID: 25756882 [TBL] [Abstract][Full Text] [Related]
16. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program. Constantine RJ; Tandon R; McPherson M; Andel R J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):79-84. PubMed ID: 21288122 [TBL] [Abstract][Full Text] [Related]
17. Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008. Fontanella CA; Warner LA; Phillips GS; Bridge JA; Campo JV Psychiatr Serv; 2014 Nov; 65(11):1332-40. PubMed ID: 25022817 [TBL] [Abstract][Full Text] [Related]
18. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications. Pennap D; Burcu M; Safer DJ; Zito JM Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557 [TBL] [Abstract][Full Text] [Related]
19. Medicaid prescription drug policies and medication access and continuity: findings from ten states. West JC; Wilk JE; Rae DS; Muszynski IS; Stipec MR; Alter CL; Sanders KE; Crystal S; Regier DA Psychiatr Serv; 2009 May; 60(5):601-10. PubMed ID: 19411346 [TBL] [Abstract][Full Text] [Related]
20. Test Accuracy of the Screening Tool for Early Predictors of Post-traumatic Stress Disorder for Post-injury Mental Health in a Managed-Medicaid Population. Buchanan L; Bushroe K; Malthaner L; McCarthy T; Zhao S; Hade E; Leonard JC J Pediatr; 2019 Jul; 210():127-133. PubMed ID: 31056203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]